Ursodeoxycholic Acid
We manufactures Ursodeoxycholic Acid. It is a mammalian bile acid found first in the bear and is apparently each a precursor or a product of chenodeoxycholate Call us +91-11-4706 3600.
Research
& Development:
(Approved by Department of Scientific
& Industrial Research, (DSIR))
Kimia Biosciences R&D is committed
to research and development of improved generic drugs with the goal of
addressing unmet patient needs with more meticulous resources and to establish
a robust portfolio for a new generation of treatments. Kimia is committed to do
significant investments in drug research and development in order to produce
effective, safe and affordable medicines. Citicoline Sodium
Infrastructure:
Kimia R&D has well equipped
Analytical Lab, synthetic Lab and Intellectual property cell, where each
scientist has access to Sci-finder search tools. The Analytical Research lab
comprises of HPLC, GC, GC-HS, Auto-Titrator, Polarimeter, UV spectrophotometer,
IR spectrophotometer etc. There are dedicated hoods for each scientist in the
synthetic lab with Rotavapours, Vacuum & Air dryers, cooling units,
mechanical and magnetic stirrers, vacuum systems Instrumentation, scientific
and analytical knowledge base at the R&D Centre facilitate: Rifaximin
Impurity profiling for the APIs
Development of Analytical methods and
their validations
Specifications from Raw materials to
Non-pharmacopoeia Finished products
Accelerated and Real time stability
studies
Expertise:
The expertise of R&D teams covers
products across various therapeutic categories including Ant diabetics &
Anti-hypertensive. Imidazole
Hydrochloride
Chiral chemistry
Synthesizing building blocks
Reactions: Pressure, Cryogenic, Metal
hydride,Catalytic, Aliphatic-Aromatic-Heterocyclic, & Multi-step synthesis,
Polymorphism
Particle Size
Bulk density
Impurities synthesis
Quality by Design approach
DOE
slider-img-seventh
Culture:
We are committed to create a culture of
respect and dignity of each individual based on humanistic values at
Kimiabiosciences where the individuality of each person is respected. Acotiamide
Hydrochloride Hydrate
Speed:
Kimia strives hard and give their best
to help meet customer deadlines with ICH quality products; the average time
todevelop a process technology is 6-8 months. benidipine
hydrochloride
Innovation:
Chiral reductions using homogeneous
catalyst
Chiral reduction using Enzymatic Technologies,
Polymorphs Processes and Techniques,
Process innovations to achieve benchmark
costs
Patents
TNo. of patent applications filed: 4
R&D
Scientists:
The team of Scientists at Kimia R&D
involves people from diverse backgrounds who uses their vast experience &
innovativeness and are determined to make Kimia R&D as an advance Centre
for Research.
Quality:
The Kimia R&D is committed to
produce drugs of high quality based on principles of quality by design and ICH
requirements
New products developed:
Prucalopride succinate
Azelnidipine
Location:-974,
Aggarwal Millennium Tower II, Netaji Subhash Place, Pitampura, New Delhi-110
034
Contact
Number:-91-11-4706 3600
Email:-info@kimiabiosciences.com
Visit
us:- http://kimiabiosciences.com/
Comments
Post a Comment